Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) FCF Margin (2018 - 2025)

Viemed Healthcare's FCF Margin history spans 8 years, with the latest figure at 30.47% for Q4 2025.

  • For Q4 2025, FCF Margin rose 2527.0% year-over-year to 30.47%; the TTM value through Dec 2025 reached 19.21%, up 1862.0%, while the annual FY2025 figure was 19.21%, 1862.0% up from the prior year.
  • FCF Margin reached 30.47% in Q4 2025 per VMD's latest filing, up from 24.4% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 52.63% in Q3 2022 to a low of 27.5% in Q3 2021.
  • Average FCF Margin over 5 years is 10.29%, with a median of 9.92% recorded in 2021.
  • Peak YoY movement for FCF Margin: surged 8013bps in 2022, then crashed -4572bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 6.23% in 2021, then soared by 229bps to 20.49% in 2022, then crashed by -223bps to 25.23% in 2023, then surged by 121bps to 5.2% in 2024, then soared by 486bps to 30.47% in 2025.
  • Per Business Quant, the three most recent readings for VMD's FCF Margin are 30.47% (Q4 2025), 24.4% (Q3 2025), and 18.91% (Q2 2025).